Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
about
In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.Angelica gigas Nakai and Soluplus-Based Solid Formulations Prepared by Hot-Melting Extrusion: Oral Absorption Enhancing and Memory Ameliorating Effects.Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.Influence of degassing on hot-melt extrusion process.Interactions between drugs and polymers influencing hot melt extrusion.Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A ReviewA New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.Rapid delivery of diazepam from supersaturated solutions prepared using prodrug/enzyme mixtures: toward intranasal treatment of seizure emergencies.Optimization of hot melt extrusion parameters for sphericity and hardness of polymeric face-cut pelletsSpatial characterization of hot melt extruded dispersion systems using thermal atomic force microscopy methods: the effects of processing parameters on phase separation.Formulation and Characterization of Solid Dispersion Prepared by Hot Melt Mixing: A Fast Screening Approach for Polymer SelectionHot melt extruded amorphous solid dispersion of posaconazole with improved bioavailability: investigating drug-polymer miscibility with advanced characterisation.Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.Theoretical prediction of a phase diagram for solid dispersions.Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation.Application of hot melt extrusion for improving bioavailability of artemisinin a thermolabile drug.Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation.Polymer/Amorphous Salt Solid Dispersions of Ciprofloxacin.Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.Novel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluation.Melt extrusion with poorly soluble drugs - An integrated review.Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.Effect of plasticiser type on the hot melt extrusion of venlafaxine hydrochloride.
P2860
Q33767372-35958258-D8A0-4D10-BBFA-58658526B903Q35542449-23EC0EB7-1D37-45FA-BE60-EAF85C7769EAQ35664762-90E76ED3-D0C0-4AAF-A321-CD28F4649BA6Q35868365-C5DFD67C-E3F7-48B3-977A-F73516A8FA87Q36341637-DE2894AF-3F50-44E6-A8F4-F2843CE5CBF3Q38170190-3898C871-118E-47DB-B0A2-530DB87CF69BQ38270691-5BAEB866-87ED-44BB-812E-302B5DB56BA8Q38411322-5B6B45FD-DD77-4FC4-A1F5-9AE7558C3B7EQ38573948-58437398-9D9D-4FE3-A69F-D2BD3C26682EQ38619552-CF480DC5-89C3-41FF-80CB-4285DEC1B64FQ38619585-D1CA9560-325C-4733-85C4-D685F4587CB0Q38972745-4F9577C4-7FB0-4FD6-9E39-D9C683F2C790Q39302267-C0F1EE5F-42CD-4051-9FF8-810E25881AA3Q39849775-042B8D50-8DFE-41CB-8387-8FC9EABEDDCEQ40867254-16E166D8-B42D-428C-B546-40DCAEC08BFAQ41497081-B2F76F92-42D5-4830-995F-7A7099A2A150Q42114941-B57B548A-750D-4ECD-9A4E-6CDCF7F3E4B2Q43728136-E4C8D5CC-FFF2-4273-8C69-6A7FF3E04092Q45204486-F2B2D20E-6831-44C7-9C22-120988E43517Q45326562-9ACC8DFF-490C-45A2-92CB-C0021F264CC9Q47341232-FDFBDEF0-4830-4A37-A060-6D0237F68EEFQ47666562-3D0BA608-9E66-4F47-9F94-1E0A629E0FA8Q47898757-D477A297-D364-4328-B557-7764FFE4FB56Q48062570-14936A10-6FC5-4A6C-A53A-23B2B3962276Q50041443-A70B6E52-530E-475B-87CB-BC6F49247F1DQ50161058-CB4D472F-736C-412F-88D6-337DAE18EF07Q51529712-46629908-DD99-44BD-B051-7EEC73C65DCCQ54342595-36DCDDA0-6AA7-4A84-A728-CDF8C80D4C6A
P2860
Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Preparation of carbamazepine-S ...... y thermodynamic model fitting.
@en
Preparation of carbamazepine-S ...... y thermodynamic model fitting.
@nl
type
label
Preparation of carbamazepine-S ...... y thermodynamic model fitting.
@en
Preparation of carbamazepine-S ...... y thermodynamic model fitting.
@nl
prefLabel
Preparation of carbamazepine-S ...... y thermodynamic model fitting.
@en
Preparation of carbamazepine-S ...... y thermodynamic model fitting.
@nl
P2093
P1476
Preparation of carbamazepine-S ...... y thermodynamic model fitting.
@en
P2093
Ioannis Nikolakakis
Jelena Djuris
Kyriakos Kachrimanis
Svetlana Ibric
Zorica Djuric
P304
P356
10.1016/J.EJPB.2012.12.018
P407
P577
2013-01-18T00:00:00Z